Optain, a startup that built AI-powered retinal screening technology, acquired EyePACS to add its teleophthalmology network and expand access to eye-disease screening in primary care.

At 17, Amity International School student Anushka Manoj is using artificial intelligence not just to innovate but to ...

Ophthalmologists discuss how advanced imaging, MIGS, and home monitoring are reshaping decision-making in complex glaucoma ...

AI-powered retinal imaging closes healthcare gaps, enables earlier intervention, and reveals new insights into systemic ...

The team put its EKG data into an AI model to analyze minuscule changes in cardiac muscle movement that appear in the ...

A $4.5M GRDC investment into the Australian Plant Phenomics Network will equip researchers with technology to boost their ...

A $4.5 million investment in the most high-tech crop measuring equipment and infrastructure available will see Australian researchers increase their ...

Learn today's words and phrases: teeming with life, biomedical sciences, DNA sequence, breed crops, decipher the genetic code ...

Overview of the Digital Pathology MarketThe global Digital Pathology Market is projected to register a growth rate of approximately 10.5% by 2029. The increasing burden of chronic diseases such as ...

Cardiosense, a digital health company pioneering AI-enabled solutions for cardiac disease management, today announced a secondary analysis from the SEISMIC-HF I study on the performance of an AI ...

In 2019, MIT engineers, backed by the Bill & Melinda Gates Foundation, unveiled a microneedle patch that could transform how ...

A comprehensive review published in Brain Medicine illuminates the intricate connections between gut microbiota and sleep ...